Parametric Portfolio Associates’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | $17.3M | Sell |
224,642
-11,496
| -5% | -$886K | 0.01% | 1045 |
|
2021
Q4 | $20.9M | Buy |
236,138
+16,189
| +7% | +$1.43M | 0.01% | 930 |
|
2021
Q3 | $17M | Buy |
219,949
+6,345
| +3% | +$490K | 0.01% | 1018 |
|
2021
Q2 | $17.8M | Buy |
213,604
+3,347
| +2% | +$279K | 0.01% | 1020 |
|
2021
Q1 | $15.9M | Sell |
210,257
-12,256
| -6% | -$925K | 0.01% | 1314 |
|
2020
Q4 | $19.5M | Buy |
222,513
+12,032
| +6% | +$1.06M | 0.01% | 1068 |
|
2020
Q3 | $16M | Sell |
210,481
-76,372
| -27% | -$5.81M | 0.01% | 1045 |
|
2020
Q2 | $35.4M | Buy |
286,853
+62,816
| +28% | +$7.75M | 0.03% | 565 |
|
2020
Q1 | $18.9M | Buy |
224,037
+15,173
| +7% | +$1.28M | 0.02% | 815 |
|
2019
Q4 | $17.7M | Buy |
208,864
+28,815
| +16% | +$2.44M | 0.01% | 1070 |
|
2019
Q3 | $12.1M | Sell |
180,049
-44,211
| -20% | -$2.98M | 0.01% | 1299 |
|
2019
Q2 | $19.2M | Sell |
224,260
-25,057
| -10% | -$2.15M | 0.02% | 957 |
|
2019
Q1 | $22.1M | Sell |
249,317
-63,743
| -20% | -$5.66M | 0.02% | 831 |
|
2018
Q4 | $26.7M | Buy |
313,060
+24,518
| +8% | +$2.09M | 0.03% | 632 |
|
2018
Q3 | $28M | Buy |
288,542
+45,036
| +18% | +$4.37M | 0.02% | 681 |
|
2018
Q2 | $22.9M | Buy |
243,506
+42,483
| +21% | +$4M | 0.02% | 757 |
|
2018
Q1 | $16.3M | Sell |
201,023
-5,491
| -3% | -$445K | 0.02% | 956 |
|
2017
Q4 | $18.4M | Buy |
206,514
+3,484
| +2% | +$311K | 0.02% | 855 |
|
2017
Q3 | $18.9M | Sell |
203,030
-8,437
| -4% | -$785K | 0.02% | 770 |
|
2017
Q2 | $19.2M | Sell |
211,467
-2,981
| -1% | -$271K | 0.02% | 691 |
|
2017
Q1 | $18.8M | Buy |
214,448
+45,955
| +27% | +$4.03M | 0.03% | 657 |
|
2016
Q4 | $14M | Buy |
168,493
+7,601
| +5% | +$630K | 0.02% | 808 |
|
2016
Q3 | $14.9M | Sell |
160,892
-7,163
| -4% | -$663K | 0.02% | 698 |
|
2016
Q2 | $13.1M | Buy |
168,055
+12,707
| +8% | +$989K | 0.02% | 752 |
|
2016
Q1 | $12.8M | Buy |
155,348
+13,408
| +9% | +$1.11M | 0.02% | 769 |
|
2015
Q4 | $14.9M | Sell |
141,940
-5,704
| -4% | -$598K | 0.03% | 638 |
|
2015
Q3 | $15.6M | Buy |
147,644
+2,213
| +2% | +$233K | 0.03% | 574 |
|
2015
Q2 | $19.9M | Sell |
145,431
-24,362
| -14% | -$3.33M | 0.04% | 483 |
|
2015
Q1 | $21.2M | Buy |
169,793
+4,843
| +3% | +$604K | 0.04% | 452 |
|
2014
Q4 | $14.9M | Buy |
164,950
+623
| +0.4% | +$56.3K | 0.03% | 577 |
|
2014
Q3 | $11.9M | Buy |
164,327
+3,954
| +2% | +$285K | 0.03% | 663 |
|
2014
Q2 | $9.98M | Sell |
160,373
-11,939
| -7% | -$743K | 0.02% | 755 |
|
2014
Q1 | $11.8M | Buy |
172,312
+8,693
| +5% | +$593K | 0.03% | 640 |
|
2013
Q4 | $11.5M | Sell |
163,619
-10,360
| -6% | -$729K | 0.03% | 642 |
|
2013
Q3 | $12.6M | Buy |
173,979
+419
| +0.2% | +$30.2K | 0.03% | 561 |
|
2013
Q2 | $9.67M | Buy |
+173,560
| New | +$9.67M | 0.03% | 641 |
|